The FDA has approved a long-acting version of the drug olanzapine (Zyprexa) for use in schizophrenia. The new version only needs to be given every two to four weeks, compared to daily doses of the current version.
Read more about the FDA's approval of long-acting olanzapine on Medpage Today.
Comments
Comments are closed for this post.
